BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21396961)

  • 1. HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays.
    Zhu Y; Curtis M; Borroto-Esoda K
    J Virol Methods; 2011 May; 173(2):340-6. PubMed ID: 21396961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
    Ji D; Liu Y; Li L; Xu Z; Si LL; Dai JZ; Li X; Wang L; Yao Z; Xin SJ; Chen GF; Xu D
    J Clin Virol; 2012 May; 54(1):66-72. PubMed ID: 22398037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis and recombinant construction of HBV the reverse transcriptase gene with drug-resistant mutations from 40 patients with chronic hepatitis B].
    Su HL; Liu Y; Liu W; Zhong YW; Chen XY; Wang CM; Liu YM; Xu DP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):340-2. PubMed ID: 20387480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication.
    Billioud G; Pichoud C; Puerstinger G; Neyts J; Zoulim F
    Antiviral Res; 2011 Nov; 92(2):271-6. PubMed ID: 21871497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
    Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
    Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.
    Liu Y; Miller MD; Kitrinos KM
    Liver Int; 2014 Aug; 34(7):1025-32. PubMed ID: 24118725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG; Song E; Burnett RJ; Mphahlele MJ
    J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic assay of a hepatitis B virus strain carrying an rtS246T variant using a new strategy.
    Hu JL; Cui J; Guo JJ; Zhang WL; Cai XF; Yuan ZW; Li QL; Deng XY; Zeng AZ; Hu Y; Tang N; Huang AL
    J Med Virol; 2012 Jan; 84(1):34-43. PubMed ID: 22052677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populations.
    Zhu Y; Curtis M; Snow-Lampart A; Yang H; Delaney W; Miller MD; Borroto-Esoda K
    J Clin Microbiol; 2007 Oct; 45(10):3335-41. PubMed ID: 17687019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hepatitis virus B isolated from a multi-drug refractory patient.
    Wei C; Chong YT; Wen JZ; Li YW; Li G
    Virus Res; 2011 Jan; 155(1):254-8. PubMed ID: 20970466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.
    Liu BM; Li T; Xu J; Li XG; Dong JP; Yan P; Yang JX; Yan L; Gao ZY; Li WP; Sun XW; Wang YH; Jiao XJ; Hou CS; Zhuang H
    Antiviral Res; 2010 Mar; 85(3):512-9. PubMed ID: 20034521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen.
    Cento V; Van Hemert F; Neumann-Fraune M; Mirabelli C; Di Maio VC; Salpini R; Bertoli A; Micheli V; Gubertini G; Romano S; Visca M; De Sanctis GM; Berkhout B; Marino N; Mazzotta F; Cappiello G; Spanò A; Sarrecchia C; Ceccherini-Silberstein F; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    J Infect; 2013 Oct; 67(4):303-12. PubMed ID: 23796863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus mutations associated with antiviral therapy.
    Bartholomeusz A; Locarnini S
    J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
    Fukai K; Zhang KY; Imazeki F; Kurihara T; Mikata R; Yokosuka O
    J Viral Hepat; 2007 Sep; 14(9):661-6. PubMed ID: 17697019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.
    Bartholomeusz A; Tehan BG; Chalmers DK
    Antivir Ther; 2004 Apr; 9(2):149-60. PubMed ID: 15134177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
    Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
    Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
    Alvarado-Esquivel C; de la Ascensión Carrera-Gracia M; Conde-González CJ; Juárez-Figueroa L; Ruiz-Maya L; Aguilar-Benavides S; Torres-Valenzuela A; Sablon E
    J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.